CVS Health (CVS) 8-K Current Report: March 19, 2026
Filed: March 19, 2026
Consumer Discretionary
Retail-Drug Stores and Proprietary StoresCVS Health (CVS) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
CVS Health 8-K Mar 19, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • John E. Gallina, former CFO of Elevance Health (2016-2023), appointed to CVS Health Board effective March 19, 2026
- • Gallina named to Audit Committee, designated audit committee financial expert under SEC rules
- • Brings nearly 30 years of finance, audit, and risk management experience in health sector
- • Board determined Gallina to be independent under NYSE corporate governance rules
- • Director compensation aligned with CVS non-employee director pay, prorated for service start date
Get deeper insights on CVS Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.